A detailed history of Legacy Capital Wealth Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Legacy Capital Wealth Partners, LLC holds 4,833 shares of NVO stock, worth $422,259. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,833
Previous 5,221 7.43%
Holding current value
$422,259
Previous $745,000 22.82%
% of portfolio
0.1%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$119.07 - $145.42 $46,199 - $56,422
-388 Reduced 7.43%
4,833 $575,000
Q2 2024

Aug 01, 2024

BUY
$122.71 - $146.91 $640,668 - $767,017
5,221 New
5,221 $745,000
Q4 2023

Feb 05, 2024

SELL
$87.78 - $105.45 $36,428 - $43,761
-415 Reduced 7.68%
4,989 $516,000
Q3 2023

Oct 16, 2023

BUY
$90.94 - $199.54 $491,439 - $1.08 Million
5,404 New
5,404 $491,000
Q1 2023

May 10, 2023

BUY
$132.34 - $159.14 $368,302 - $442,886
2,783 New
2,783 $442,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Legacy Capital Wealth Partners, LLC Portfolio

Follow Legacy Capital Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Capital Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Capital Wealth Partners, LLC with notifications on news.